Navigation Links
Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays
Date:11/13/2007

nce is an organization dedicated to improving the lives of heartburn sufferers through education, information and support. Nationally recognized health care professionals, including experts in digestive disease, pharmacy, nutrition and nursing, comprise the Alliance. The NHBA receives support and sponsorship from the P&G Health Sciences Institute (http://pghsi.com).

*Synovate Inc.'s online Global Opinion Panel was used as the sample source for this study. This is a national household database consisting of over 1.4 million households that have agreed to participate in survey research. The study included 1,000 representative interviews among adults age 18 to 65, and is balanced to be representative of the general population based upon region, gender, age and household income data from the U.S. Census Bureau. The selected individuals receive a customized e-mail inviting them to participate in the survey. The survey consists of a shared set of standard demographic questions.

(1) Copyright(C) American Gastroenterological Association;

http://www.gastro.org


'/>"/>
SOURCE National Heartburn Alliance
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Survey reveals disparities in skin cancer knowledge, protection among high school students
2. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
3. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
4. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
5. Youth Drug Use at a Five Year Low, New Survey Shows
6. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
7. Parental surveys boost diagnosis abilities of pediatricians
8. National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
9. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
10. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care
11. Launch of second European Cancer Research Funding survey

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., Fla., Dec. 1 OrbusNeich today an...e randomized clinical trial of the Combo Bio-engin... A prospective, randomized, multicenter study, REM... inal sirolimus coat ED bio- E ngineered st ...in Asia, Australia, Europe and South America . Th...
(Date:12/1/2009)...AGies Foundation will honor The Forsyth Institute ...Awards celebration to be held on February 27, 2010...ADEA Annual Session & Exhibition. The William J. G... recognize contributions to, and support of global...lete listing of Gies Award winners, visit www.ade...
(Date:12/1/2009)...ornia are unable to successfully obtain informatio...ite recent state legislation intended to improve p...osing as low-income uninsured patients, researcher...d of the hospitals they approached and the estimat...wed under California law, according to the finding...
(Date:12/1/2009)...benign versus cancerous lesions, researchers say ,...hen used with ultrasound, elastography helps disti..., which reduces unnecessary biopsies, U.S. researc...esions that are biopsied turn out to be benign, ac...e,s a lot of room to improve specificity with ultr...
(Date:12/1/2009)...ension announces general availability of its new E...nd-to-end endpoint management capabilities on a si...nsole architecture. , Sco... a global leader in endpoint management and securi...t Management and Security Suite (LEMSS) that wil...
Breaking Medicine News(10 mins):Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:Ultrasound With Elastography May Cut Down on Biopsies 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6
...ents at Major Patenting Authorities Worldwide , ,...and Science business of Thomson Reuters today rele...off Wild, editor of Intellectual Asset Management...jor patenting authorities (USA, Europe, Japan, Chi...
...estaurant Association Executive Vice President for...statement in response to today,s U.S. Court of App...ealth regulation that dictates how nutrition infor...s for the federal government to establish a unifor...
...ma Lab Internacional,S.A.B. de C.V. (BMV: LAB) ("G...rth quarter and twelve month results for the perio...erein are audited(1) and were prepared in,accordan..., 2007. Also, the following consolidated figures s...
...inal Health today,announced it has reached agreeme...an amended consent decree regarding the company,s ...operated under a consent decree since February 200...subject,to approval by the U.S. District Court for...
...er recall, study finds , , TUESDAY, Feb. 1... as reading or playing games, in middle age and la...ng to new research. , The study included 197 peopl...articipants were asked about their daily activitie...
...plements can prevent hearing loss in laboratory an...stigators one step closer to the development of a ...s even age-related hearing loss in humans. , The ...ll, Ph.D., a researcher at the University of Flori...
Other Medicine News:Health News:Thomson Reuters Releases 2009 Patent Focus Report 2Health News:National Restaurant Association Statement Regarding Federal Court Ruling on Menu Labeling in New York City 2Health News:Genomma Lab Internacional Announces Fourth Quarter and Full Year 2008 Results 2Health News:Genomma Lab Internacional Announces Fourth Quarter and Full Year 2008 Results 3Health News:Cardinal Health, FDA Amend Infusion Pump Consent Decree 2Health News:Reading, Games Help Keep Aging Memories Sharp 2Health News:Vitamin supplements may protect against noise-induced hearing loss 2Health News:Vitamin supplements may protect against noise-induced hearing loss 3
(Date:12/1/2009)... MORRISVILLE, N.C., Dec. 1 nContac...estigation of devices for minimally-invasive treat...tiation of a feasibility clinical trial designed t...urgical and catheter procedure, the convergent pro...l atrial fibrillation (AF). This prospective, fea...
(Date:12/1/2009).... LAUREL, N.J., Dec. 1 ...r of technology-enabled clinical documentation ser...ool from Primordial Design, Inc. has been integrat...-time speech recognition system. The solution is b...orth America (RSNA) convention November 29 through...
(Date:12/1/2009)..., PISCATAWAY, N.J., Dec. 1 Siemen.../hearing) a leading global manufacturer of hearing...ip with Quota International,s Sound Beginnings pro...mber 2010. ,, As part of the renewed partnershi...chers for 100 free hearing instruments to both chi...
Breaking Medicine Technology:nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3Leave Worries Behind When Packing for Vacation 53417 1Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS SaaS Clinical Trials Collaboration Software 13315 1Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS SaaS Clinical Trials Collaboration Software 13315 2Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS SaaS Clinical Trials Collaboration Software 13315 3Fastrack Release First Integrated HME Billing Infusion Pharmacy 26amp 3B Home Care Agency Software in a Microsoft Environment 53415 1Fastrack Release First Integrated HME Billing Infusion Pharmacy 26amp 3B Home Care Agency Software in a Microsoft Environment 53415 2
...., Nov. 4 Micromet, Inc. (Nasdaq:,MITI), a biopha...antibodies,for the treatment of cancer, inflammati...reclinical study(1) showing cytotoxic activity of,...RAS-mutated human colon,cancer cells on November 1...onal Society for Biological Therapy of Cancer (iSB...
...Calif., Nov. 3 Bionovo, Inc.,(Nasdaq: BNVI ) ann...c,breast cancer, BZL101, will advance to Phase 2 c... a second Phase 1 clinical trial., The Phase 1B c...m,tolerated dose of BZL101 and to determine the sa... anticancer treatment. A total of 27 women with,me...
Other Medicine Technology:Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 2Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 3Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 4Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 5Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 2Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 3Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 4
Concave bar electrode
Plume-Inator®
SAFE® System Surgical Smoke Evacuation System
T4 Personal Protection System
Medicine Products: